Kampanjeplan TransMedics Group, Inc.
Om selskapet
TransMedics Group, Inc., коммерческая медицинская технологическая компания, занимается преобразованием терапии трансплантации органов для пациентов с терминальной стадией недостаточности органов в Соединенных Штатах и за рубежом. Компания предлагает Organ Care System (OCS), портативную систему перфузии, оптимизации и мониторинга органов, в которой используется запатентованная и адаптированная технология для воспроизведения почти физиологических условий для донорских органов вне человеческого тела.
Flere detaljerЦена ао | 83.59 |
---|---|
Выручка | 0.0236 |
EBITDA | -0.0288 |
P/S | 11.34 |
EV/EBITDA | -9.78 |
P/BV | 4.9 |
Сайт | https://www.transmedics.com |
ISIN | US89377M1099 |
Число акций ао | 0.03252 млрд |
Валюта | usd |
IPO date | 2019-05-02 |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Валюта отчета | usd |
Prisendring per dag: | -6.02% (88.92) |
---|---|
Prisendring per uke: | -38.51% (135.9) |
Prisendring per måned: | -46.46% (156.08) |
Prisendring over 3 måneder: | -42.13% (144.4) |
Prisendring over seks måneder: | -0.701% (84.16) |
Prisendring per år: | +103.14% (41.14) |
Prisendring over 3 år: | +212.41% (26.75) |
Prisendring over 5 år: | +251.13% (23.8) |
Prisendring siden begynnelsen av året: | +21.2% (68.95) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Transaksjonsdato | Avsløringsdato | Insider | Type | Pris | Volum | Mengde | Del opp til, % | Del etterpå, % | Dokument |
---|---|---|---|---|---|---|---|---|---|
16.09.2024 | 17.09.2024 | Hassanein Waleed H President & CEO |
Salg | 153.42 | 1 323 250 | 8625 | 0 | -0.03 | link |
16.09.2024 | 17.09.2024 | Hassanein Waleed H President & CEO |
Kjøpe | 13.28 | 114 540 | 8625 | 0 | 0.03 | link |
15.08.2024 | 19.08.2024 | Hassanein Waleed H President & CEO |
Salg | 169.73 | 1 463 920 | 8625 | 0 | -0.03 | link |
15.08.2024 | 19.08.2024 | Hassanein Waleed H President & CEO |
Kjøpe | 13.28 | 114 540 | 8625 | 0 | 0.03 | link |
08.08.2024 | 08.08.2024 | James R. Tobin Director |
Kjøpe | 145.85 | 2 917 000 | 20000 | 0 | 0.07 | link |
01.08.2024 | 01.08.2024 | Tamer Khayal Officer |
Kjøpe | 163.81 | 1 453 980 | 8876 | 0 | 0.03 | link |
10.04.2024 | 12.04.2024 | Hassanein Waleed H President & CEO |
Salg | 95.09 | 1 141 080 | 12000 | 0 | -0.04 | link |
10.04.2024 | 12.04.2024 | Hassanein Waleed H President & CEO |
Kjøpe | 13.28 | 159 360 | 12000 | 0 | 0.04 | link |
08.03.2024 | 12.03.2024 | Gordon Stephen Chief Financial Officer |
Salg | 87.63 | 166 760 | 1903 | 0 | -0.01 | link |
08.03.2024 | 12.03.2024 | Khayal Tamer I Chief Commercial Officer |
Salg | 87.8 | 124 413 | 1417 | 0 | -0.01 | link |
08.03.2024 | 12.03.2024 | Khayal Tamer I Chief Commercial Officer |
Kjøpe | 16.14 | 1 614 | 100 | 0 | 0 | link |
04.03.2024 | 05.03.2024 | Gordon Stephen Chief Financial Officer |
Salg | 82.8 | 1 242 000 | 15000 | 0 | -0.05 | link |
04.03.2024 | 05.03.2024 | Gordon Stephen Chief Financial Officer |
Kjøpe | 38.46 | 576 900 | 15000 | 0 | 0.05 | link |
07.02.2024 | 09.02.2024 | Khayal Tamer I Chief Commercial Officer |
Salg | 90.09 | 66 306 | 736 | 0 | 0 | link |
07.02.2024 | 09.02.2024 | Khayal Tamer I Chief Commercial Officer |
Kjøpe | 16 | 11 776 | 736 | 0 | 0 | link |
Institusjoner | Volum | Dele, % |
---|---|---|
FMR, LLC | 4828744 | 14.76 |
Blackrock Inc. | 2550255 | 7.8 |
Vanguard Group Inc | 1865115 | 5.7 |
Macquarie Group Limited | 1525819 | 4.66 |
Fred Alger Management, LLC | 1342915 | 4.11 |
Invesco Ltd. | 1140851 | 3.49 |
Driehaus Capital Management, LLC | 1090507 | 3.33 |
Lord, Abbett & Co. LLC | 1025564 | 3.14 |
ArrowMark Colorado Holdings LLC | 1020838 | 3.12 |
Eventide Asset Management LLC | 994240 | 3.04 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Dr. Waleed H. Hassanein M.D. | Founder, President, CEO & Director | 1.46M | 1968 (56 år) |
Mr. Stephen Gordon | CFO, Treasurer & Secretary | 744.62k | 1968 (56 år) |
Dr. Tamer I. Khayal M.D. | Chief Commercial Officer | 748.78k | 1969 (55 år) |
Ms. Miriam C. Provost Ph.D. | Vice President of Global Regulatory Affairs | 535.93k | 1961 (63 år) |
Mr. Anil Ranganath | Senior VP, General Counsel & Corporate Secretary | N/A | |
Mr. Nicholas Corcoran | Senior Vice President of Supply Chain & Operations | 1983 (41 år) |
Nettsted: https://www.transmedics.com